This compound is a sulfur-containing amino acid derivative with adenine and ribose moieties, characterized by five hydrogen bond donors, high polarity, and multiple ring systems. It is primarily documented as a pharmaceutical intermediate.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 53276-26-9
(E,E)-[3-methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)penta-2,4-dienyl]triphenylphosphonium chloride
pharmaceutical intermediate
Cis-4-(tert-Butoxycarbonylamino)cyclohexanecarboxylic acid
pharmaceutical intermediate
Benzenesulfonamide, 4-amino-3-chloro-
pharmaceutical intermediate
D-2-deoxyribose
pharmaceutical intermediate
2-Amino-4-(((5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methyl)sulfanyl)butanoic acid
pharmaceutical raw material
S-adenosyl-L-homocysteine zwitterion
research compound
(2R)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]butanoic acid
ZJUKTBDSGOFHSH-KWGHVAAJSA-N
C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CSCC[C@H](C(=O)O)N)O)O)N
—